Front Row Advisors LLC Merck & Co., Inc. Transaction History

Front Row Advisors LLC

  • $271 Million
  • Q3 2024

A detailed history of Front Row Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 306 shares of MRK stock, worth $30,349. This represents 0.01% of its overall portfolio holdings.

Number of Shares
306
Previous 434 29.49%
Holding current value
$30,349
Previous $53,000 35.85%
% of portfolio
0.01%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$111.15 - $128.97 $14,227 - $16,508
-128 Reduced 29.49%
306 $34,000
Q1 2024

May 14, 2024
BUY
$113.24 - $131.95 $20,156 - $23,487
178 Added 69.53%
434 $57,000
Q4 2023

Feb 15, 2024
SELL
$100.18 - $109.02 $12,823 - $13,954
-128 Reduced 33.33%
256 $27,000
Q3 2023

Nov 15, 2023
BUY
$102.95 - $114.33 $2,161 - $2,400
21 Added 5.79%
384 $39,000
Q1 2023

May 22, 2023
BUY
$102.94 - $114.86 $33,352 - $37,214
324 Added 830.77%
363 $39,000
Q1 2023

May 15, 2023
SELL
$102.94 - $114.86 $23,470 - $26,188
-228 Reduced 85.39%
39 $36,000
Q4 2022

Feb 15, 2023
SELL
$87.44 - $112.11 $3,322 - $4,260
-38 Reduced 12.46%
267 $30,000
Q3 2022

Nov 15, 2022
SELL
$84.53 - $94.96 $1,690 - $1,899
-20 Reduced 6.15%
305 $27,000
Q2 2022

Aug 15, 2022
SELL
$83.49 - $94.64 $1,168 - $1,324
-14 Reduced 4.13%
325 $30,000
Q4 2021

Mar 09, 2022
BUY
$72.28 - $90.54 $11,564 - $14,486
160 Added 89.39%
339 $26,000
Q2 2021

Aug 23, 2021
BUY
$70.31 - $77.77 $70 - $77
1 Added 0.56%
179 $14,000
Q3 2020

Nov 30, 2020
SELL
$73.18 - $82.95 $5,122 - $5,806
-70 Reduced 28.23%
178 $14,000
Q2 2020

Aug 17, 2020
SELL
$70.42 - $80.13 $1,619 - $1,842
-23 Reduced 8.49%
248 $19,000
Q1 2020

May 08, 2020
BUY
$63.36 - $87.82 $63 - $87
1 Added 0.37%
271 $22,000
Q4 2019

Feb 14, 2020
SELL
$77.58 - $87.54 $1,396 - $1,575
-18 Reduced 6.25%
270 $25,000
Q2 2019

Aug 27, 2019
SELL
$69.84 - $81.59 $1,955 - $2,284
-28 Reduced 8.86%
288 $24,000
Q1 2019

May 17, 2019
BUY
$69.58 - $79.36 $4,940 - $5,634
71 Added 28.98%
316 $26,000
Q4 2018

Feb 13, 2019
SELL
$65.24 - $75.71 $15,135 - $17,564
-232 Reduced 48.64%
245 $19,000
Q3 2018

Nov 13, 2018
BUY
$57.69 - $67.84 $4,557 - $5,359
79 Added 19.85%
477 $34,000
Q1 2018

May 21, 2018
BUY
$50.96 - $59.23 $4,892 - $5,686
96 Added 31.79%
398 $22,000
Q4 2017

Feb 01, 2018
BUY
$51.62 - $61.64 $15,589 - $18,615
302
302 $17,000

Others Institutions Holding MRK

# of Institutions
3,820
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email